Title
Category
Credits
Event date
Cost
Recent Advances in Screening for Mild Cognitive Impairment and Alzheimer Disease
  • Alzheimer Disease
  • Cognition
  • Dementia
  • Geriatric Psychiatry
  • Neurology
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Participation
$0.00
Among the most transformative Alzheimer Disease discoveries is the existence of biomarkers which can manifest decades before onset of disease-related dementia.
The Differential Diagnosis and Treatment of Mild Cognitive Impairment and Alzheimer Disease
  • Alzheimer Disease
  • Cognition
  • Dementia
  • Geriatric Psychiatry
  • Neurology
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Participation
$0.00
Navigating the associated differential diagnosis in AD is essential as various causes of cognitive impairment require different treatment strategies.
Facilitating Treatment Initiation in Early-Stage Alzheimer Disease
  • Alzheimer Disease
  • Dementia
  • Integrated Care
  • Neuroimaging
  • Patient/Physician Communication
  • Primary Care
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Participation
$0.00
Many new therapies for early-stage AD have made their way onto the scene that can delay onset of the disease and/or slow down progression. Find out the how, what, when to better treat your patients with AD from specialists in the field.
Timely Diagnosis of Alzheimer Disease
  • Alzheimer Disease
  • Dementia
  • Neuroimaging
  • Primary Care
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Participation
$0.00
Early-stage diagnosis of Alzheimer disease leads to prompt treatment initiation and better patient QoL. Learn about new guidelines and technology advances and what’s on the horizon from authorities in the field.